FOLH1 and prostate carcinoma: Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is highly expressed in prostate cancer cells, particularly in advanced and metastatic stages of the disease, and its expression levels increase as tumor aggressiveness escalates [8].